NEW: Redenlab commence work with Melbourne Brain Centre & The University of Melbourne on speech testing for clinical trial in Dravet Syndrome

Posted on July 31, 2017
by Redenlab
acoustic

NEW: Redenlab commence work with Melbourne Brain Centre & The University of Melbourne on speech testing for clinical trial in Dravet Syndrome

Posted on July 31, 2017
by Redenlab
acoustic

Tags: clinical trials, epilepsy, neurodevelopmental, speech

Related Post

Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases

Posted on 25 January, 2024

MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a groundbreaking study...

Read more

Acoustic analysis of the effects of sustained wakefulness on speech

Posted on 25 January, 2024

Exposing healthy adults to extended periods of wakefulness is known to induce changes in psychomotor functioning. The effect of fatigue...

Read more

Perceptual and acoustic analysis of speech in spinocerebellar ataxia type 1

Posted on 10 March, 2023

Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...

Read more